Cargando…

Small bowel enteropathy associated with olmesartan medoxomil treatment

Sprue-like enteropathy associated with treatment with olmesartan medoxomil, an angiotensin II receptor blocker, has been described recently. Herein, we report two patients who developed chronic severe non-bloody diarrhea, weight loss, and muscle wasting after prolonged use of olmesartan. Histologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galanopoulos, Michail, Varytimiadis, Lazaros, Tsigaridas, Athanasios, Karatzas, Pantelis S., Archavlis, Emmanuel, Viazis, Nikos, Vourlakou, Christina, Mantzaris, Gerassimos J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198241/ https://www.ncbi.nlm.nih.gov/pubmed/28042253 http://dx.doi.org/10.20524/aog.2016.0052

Ejemplares similares

Effective colonoscopy training techniques: strategies to improve patient outcomes
por: Papanikolaou, Ioannis S, et al.
Publicado: (2016)

A forgotten nasogastric feeding tube that refuses to get out
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Olmesartan-medoxomil: Sprue-like enteropathy: case report
Publicado: (2021)

Simethicone adjunct to polyethylene glycol improves small bowel capsule endoscopy imaging in non-Crohn’s disease patients
por: Papamichael, Konstantinos, et al.
Publicado: (2015)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006)

Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
por: Rote, A. R., et al.
Publicado: (2010)

Olmesartan medoxomil for the treatment of hypertension in children and adolescents
por: Tocci, Giuliano, et al.
Publicado: (2011)

Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil
por: Prajapati, Shailesh T., et al.
Publicado: (2013)

Olmesartan medoxomil: Allergic reaction: case report
Publicado: (2022)

Secondary metastatic lesions to colon and rectum
por: Galanopoulos, Michail, et al.
Publicado: (2018)

DNA Methylation Profile of Genes Involved in Inflammation and Autoimmunity in Inflammatory Bowel Disease
por: Karatzas, Pantelis S., et al.
Publicado: (2014)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Olmesartan medoxomil: current status of its use in monotherapy
por: Brunner, Hans R
Publicado: (2006)

Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
por: Thakkar, Hetal Paresh, et al.
Publicado: (2011)

Olmesartan-Induced Spruelike Enteropathy: An Emerging Cause of Small Bowel Injury
por: Malik, Adnan, et al.
Publicado: (2020)

COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract
por: Galanopoulos, Michail, et al.
Publicado: (2020)

Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
por: Punzi, Henry A
Publicado: (2011)

Linear mixed‐effects model of QTc prolongation for olmesartan medoxomil
por: Song, SaeHeum, et al.
Publicado: (2016)

Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
por: Ferrario, Carlos
Publicado: (2009)

Simultaneous Estimation of Amlodipine Besilate and Olmesartan Medoxomil in Pharmaceutical Dosage Form
por: Wankhede, S. B., et al.
Publicado: (2009)

Human Carboxymethylenebutenolidase as a Bioactivating Hydrolase of Olmesartan Medoxomil in Liver and Intestine
por: Ishizuka, Tomoko, et al.
Publicado: (2010)

Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments
por: Almutairy, Bjad K., et al.
Publicado: (2021)

Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
por: Kumar, Lakshya, et al.
Publicado: (2023)

Olmesartan-Induced Sprue Like Enteropathy
por: Carneiro, Liliana, et al.
Publicado: (2016)

Rare Case of Olmesartan Induced Enteropathy
por: Handa, Richa, et al.
Publicado: (2017)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
por: Mason, R Preston
Publicado: (2011)

Derivative and Q-analysis Spectrophotometric Methods for Estimation of Hydrochlorothiazide and Olmesartan Medoxomil in Tablets
por: Bhusari, K. P., et al.
Publicado: (2009)

Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
por: Chrysant, S G, et al.
Publicado: (2010)

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation
por: El-Dahmy, Rania Moataz, et al.
Publicado: (2023)

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
por: Sohn, Il Suk, et al.
Publicado: (2015)

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Olmesartan‐induced enteropathy associated with cutaneous lesions
por: Hammoudi, Nassim, et al.
Publicado: (2016)

A Case Report of Olmesartan-Induced Enteropathy
por: Daines, Benjamin S, et al.
Publicado: (2021)

Olmesartan-Induced Enteropathy: A Case Report
por: Jadvani, Dharmikkumar, et al.
Publicado: (2023)

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
por: Sohn, Il Suk, et al.
Publicado: (2016)

Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?
por: Lourenço, Luís Carvalho, et al.
Publicado: (2016)

Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block
por: Hujoel, Isabel A., et al.
Publicado: (2016)

A Competent and Commercially Viable Process for the Synthesis of the Anti-Hypertensive Drug Olmesartan Medoxomil
por: Hanumantha Rao, Bommena, et al.
Publicado: (2015)

Enhanced ex vivo intestinal absorption of olmesartan medoxomil nanosuspension: Preparation by combinative technology
por: Attari, Zenab, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5m696k0qkckgenqolsiki1g2bu